The report notes revenue declined 14.2% YoY to Rs 476.7 crore and net profit fell 79% YoY, though H2 FY27 is expected to be materially stronger.
Read this note →Cohance Lifesciences Limited
NSE COHANCE BSE 543064 INE03QK01018
0 filings · 0 analysed
443.65
+0.60%
over 1 month
-
The report notes revenue declined 14.2% YoY to Rs 476.7 crore and net profit fell 79% YoY, though H2 FY27 is expected to be materially stronger.
Prices from Yahoo Finance, NSE close, delayed — indicative only, not for dealing. Solid markers sit on the exchange's own timestamp.
What the desks said
Announcement timeline
No filings stored for this company yet.
Never miss the next one.
Orivam emails what the research desks published each trading morning, attributed and linked to the original notes. Free.
Get the daily brief